BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15229610)

  • 1. Starting from scratch.
    Chapman T
    Nature; 2004 Jul; 430(6995):113. PubMed ID: 15229610
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modelling.
    Barril X; Soliva R
    Mol Biosyst; 2006 Dec; 2(12):660-81. PubMed ID: 17216047
    [No Abstract]   [Full Text] [Related]  

  • 3. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 6. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification of bioactive natural products by structure activity relationship.
    Zhou X; Li Y; Chen X
    J Mol Graph Model; 2010 Aug; 29(1):38-45. PubMed ID: 20488738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 as a target for drug development.
    Chaudhury S; Welch TR; Blagg BS
    ChemMedChem; 2006 Dec; 1(12):1331-40. PubMed ID: 17066389
    [No Abstract]   [Full Text] [Related]  

  • 14. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction.
    Kazantsev AV; Karamertzanis PG; Adjiman CS; Pantelides CC; Price SL; Galek PT; Day GM; Cruz-Cabeza AJ
    Int J Pharm; 2011 Oct; 418(2):168-78. PubMed ID: 21497184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond.
    Abad-Zapatero C
    Drug Discov Today; 2007 Dec; 12(23-24):995-7. PubMed ID: 18061876
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets.
    Bottegoni G; Rocchia W; Recanatini M; Cavalli A
    Bioinformatics; 2006 Jul; 22(14):e58-65. PubMed ID: 16873522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.